Clinical Trial Update: 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update of 68Ga-AlfatideII for differentiating lung cancer from pulmonary tuberculosis using PET/CT in Phase 1/Phase 2 (status: completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Tuberculosis

Drugs mentioned

• 68Ga-AlfatideII

Snippet

Sponsor: Xijing Hospital | Conditions: Lung Cancer, Lung Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED